Fig 4.

Allergen-specific IgE levels during two treatment years with BM32 or placebo in patients. (A) Phl p 1-, (B) Phl p 2-, (C) Phl p 5- and (D) Phl p 6-specific IgE levels (y-axes: kUA/l) are shown for the patients sensitized to the corresponding allergens at indicated time points (x-axes) Dots (Placebo: red circles, BM32: blue squares) represent individual patients and lines represent the means. Differences between BM32-treated and placebo group are indicated. (* = p < .05 and n.s. = not significant).